Policy

Ed Thompson, president of Pharmaceutical Manufacturing Research Services, explained to attendees at the Rx Drug Abuse & Heroin Summit why he wants the FDA to start requiring substantial scientific evidence of efficacy for the intended use of new…

From interagency collaborations to opioid use disorder treatment through telemedicine, communications prove key in projects discussed at Rx Drug Abuse & Heroin Summit.

The American Academy of Nursing has issued a policy brief calling for an end to criminalization of maternal substance use in favor of a public health strategy.

President Donald J. Trump and First Lady Melania Trump will address participants of the eighth annual Rx Drug Abuse & Heroin Summit on April 24 in Atlanta.

Health officials in 22 states and territories want the federal government to lift some of the restrictive regulations that limit the prescribing of buprenorphine for opioid use disorder.

The New Jersey Department of Human Services has announced that the state’s Medicaid plans will no longer require prior authorization for medication-assisted treatment for opioid use disorder.

At this month's National Rx Drug Abuse & Heroin Summit, Robert Valuck, PhD, will present key advocacy strategies to achieve results in combating the opioid crisis.

As we develop the capacity to promote more effective decarceration practices, it also will be important to be very clear about how we undertake this work. Here are a series of action items to facilitate this effort.

It's time to abandon the practice of having mental health criteria being developed by payers and replace it with an approach comparable to the ASAM guidelines.

A harsh ruling against United Behavioral Healthcare for failing to meet generally accepted standards of care in its internal guidelines for behavioral healthcare coverage could have a lasting impact for the industry as a whole.